Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2111402 Target Snapshot

5-lipoxygenase/FLAP · PROTEIN COMPLEX · Homo sapiens

29Compounds
12Assays
0Approved Drugs
37.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P09917. Use UniProt P09917 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P09917 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 5-lipoxygenase/FLAP as ChEMBL target CHEMBL2111402, mapped to UniProt P09917. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
5-lipoxygenase/FLAP
PROTEIN COMPLEX · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2111402
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P09917
Polyunsaturated fatty acid 5-lipoxygenase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 5-lipoxygenase/FLAP is the right protein anchor across sources, using UniProt P09917 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPolyunsaturated fatty acid 5-lipoxygenase
UniProt AccessionP09917
Component TypeProtein
Sequence Length674 aa

Polyunsaturated fatty acid 5-lipoxygenase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 5-lipoxygenase/FLAP, mapped to UniProt P09917. ChEMBL maps the protein component as Polyunsaturated fatty acid 5-lipoxygenase. Sequence length is 674 aa.

Mapped IDP09917
Review name5-lipoxygenase/FLAP
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Phase II
Assay Mix

Activity Type Distribution

IC5037.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL29097 7.52 IC50 30.0 Preclinical
CHEMBL289751 7.4 IC50 40.0 Preclinical
CHEMBL38958 7.3 IC50 50.0 Preclinical
CHEMBL3349448 7.0 IC50 100.0 Preclinical
CHEMBL39617 6.96 IC50 110.0 Preclinical
CHEMBL290170 6.82 IC50 150.0 Preclinical
CHEMBL39189 6.77 IC50 170.0 Preclinical
CHEMBL36331 6.75 IC50 180.0 Preclinical
CHEMBL434401 6.75 IC50 180.0 Preclinical
CHEMBL16596 6.7 IC50 200.0 Clinical
Distribution

pChEMBL Value Distribution

6
5.0
4
5.5
8
6.0
8
6.5
3
7.0
1
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

12
Total Assays
37
Tested Compounds
2
Assay Types
Binding — 10 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
protein complex format 10 0
Functional — 2 assays, 37 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 18 5.7
tissue-based format 1 19 6.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine